Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Reefer Madness Redux
By Michael Lawrence Langan MD
Cannabis, also known as marijuana and by numerous other names, is a preparation of the Cannabis plant intended for use as a psychoactive drug or medicine.
The main psychoactive part of cannabis is tetrahydrocannabinol (THC); it is one of 483 known compounds in the plant, including at least 84 other cannabinoids, such as cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabivarin (THCV).
Source: https://en.wikipedia.org/wiki/Cannabis_(drug)
***
[Clandestine Grow Lab at Home]
***
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
***
Share this:
Filed under: Ethics, Risk Management | Tagged: Is your doctor a marijuana user?, medical marijuana, Michael Lawrence Langan MD, pot, Reefer Madness Redux, tetrahydrocannabinol, THC |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
“Healthcare Triage: What We Know about Pot in 2017”
Marijuana! You guys always want to know more about pot from Healthcare Triage. It’s also one of the most controversial and complex subjects we cover. And it’s time for an update on what we know, versus what we think, when it comes to the drug.
Here’s the study itself.
http://theincidentaleconomist.com/wordpress/healthcare-triage-what-we-know-about-pot-in-2017/
Aaron Carroll MD
via Ann Miller RN MHA
LikeLike
POT Ads
CBS has reportedly rejected a pro-medical marijuana Super Bowl ad.
http://www.msn.com/en-us/sports/nfl/cbs-has-reportedly-rejected-a-pro-medical-marijuana-super-bowl-ad/ar-BBSAKZx?li=BBnbfcL
Well done.
Dr. David Edward Marcinko MBA
LikeLike
POT or NOT
I’m not sure if I am pro or anti pot use. I think this gentleman makes a great point that if you are ‘pro’ you will see all the benefits and if you are ‘anti’ you will emphasize the risks.
I think if alcohol is legal, marijuana probably should be. I don’t know anyone that smokes a joint and then drives really fast and wrecks somewhere or is being called for domestic abuse! I could be wrong, but most want to snack a little bit and watch Netflix…
JOE
LikeLike
Do you drink? Do you smoke cigarettes? Do you use cannabis?”
That last question is becoming more common in medical practices across the country—and the answer could have major implications when it comes to elective surgeries and procedures.
With cannabis now legal for either medicinal or recreational use (or both) in many states, the American Society of Regional Anesthesia (ASRA) and Pain Medicine released recommended guidelines in January to help anesthesiologists gauge how often a patient uses cannabis (and in what form) before they’re sedated for a procedure.
It’s not a totally new concept. Some physicians have asked patients for years about cannabis use, but that’s varied from state to state and from medical office to medical office.
Even if those conversations happen in primary care settings, surgeons don’t routinely screen patients for marijuana use as part of their standard of care, said David Dickerson, who chairs the American Society of Anesthesiologists’ Committee on Pain Medicine.
Kessler
LikeLike